The Good News: "Geron Is Shutting Down Its Stem Cell Clinical Trial"

While it is good news, the NY Slimes story makes sure that there is plenty of spin in it to continue pushing for embryonic stem cell research while doing nothing to make it clear that adult stem cells are already giving real hope rather than the false promises they continue to offer to justify using embryonic stem cells. In fact, to read the entire article you wouldn't even know of the 80+ treatments already out there in use or far along in development. In the 4th to the last paragraph it does finally admit to their existance. But this is all it says: "There are many other trials for a variety of diseases using so-called adult stem cells, which are not as controversial."

Nor does this mean the end of the research Geron was doing. As the story reports, Geron hopes to sell or license the stem cell program to another company that would continue it.

Additionally, as Rebecca Taylor reports in the LifeNews story I 1st read about this in: "Geron’s retreat is sure to be a rallying cry to increase federal funding for embryonic stem cell research." & you can be sure the speeches are being readied even as I write this as will as bills being prepared for intorduction in Congress by the "culture of death" allies there.

As I said above, the article gives short shrift to the success stories with adult stem cells, but it does go on to promote 2 other clinic trials using embryonic stem cells.

Not only that, there is additional spin via Dr. Robert Lanza, the chief scientific officer of Advanced Cell Technology, 1 of those still doing embryonic research. He said Geron’s move was “very unfortunate for the field” and “puts the pressure on us now.”
He added that spinal cord injury “was not the ideal first indication for an embryonic stem cell therapy. Everyone knew it was going to be very difficult to show efficacy.” Again no mention that adult stem cells have shown plenty of "efficacy". (Adult Stem Cells Help Spinal Cord Injury)

As I said, this is good news in the short run. We cannot just be happy 1 company has quit & leave it at that. But as I have also pointed out, this will be used, not to admit the truth, but as another means to push for more federal funding. We must be ready to answer those calls for more funding with the truth about adult stem cells. If we don't, then they will win in the long run by default.

Source: Company Halts First Human Embryonic Stem Cell Research Trial